Literature DB >> 804436

Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs.

T J Meyer, I Azuma, E E Ribi.   

Abstract

The efficacy of various fractions of mycobacterial cell walls in producing experimental ahlergic encephalomyelitis (EAE) has been evaluated. BCG (Bacillus-Calmette-Buérin) cell walls were effective in producing EAE in all animals at dose levels as low as 40 mug. Study of subfractions of these cell walls revealed the following: (1) wax D was active, but required larger doses than BCG cell walls; (2) the chloroform-methanol-soluble (CMS) portion of wax D and P3 (a mycolic acid-trehalose ester contained therein) were inactive; (3) the chloroform-methanol-insoluble (CMI) portion of wax D was active; (4) exhaustively delipidated cell wass skeletons of BCG, Nocardia asteroides, Mycobacterium smegmatis, Corynebacterium diphtheriae and M. kansaii were active; (5) two water-soluble adjuvants prepared from mycobacteria were active. These results suggest that the mycobacterial structure responsible for EAE adjuvanticity is present in the organic solvent-insoluble cell wall skeleton framework. The activity of wax D may be due to the presence of cell-wall skeleton constituents which are found in varying quanity in most wax D preparations. Wax D components soluble in a solution of chloroform:methanol (diluted 2:1 v/v) do not produce EAE.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 804436      PMCID: PMC1445816     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  CORRELATION OF ADJUVANT ACTIVITY AND CHEMICAL STRUCTURE OF WAX D FRACTIONS OF MYCOBACTERIA.

Authors:  R G WHITE; P JOLLES; D SAMOUR; E LEDERER
Journal:  Immunology       Date:  1964-03       Impact factor: 7.397

2.  Partial chemical characterization of the cell wall of Nocardia asteroides strain 131.

Authors:  I Azuma; F Kanetsuna; Y Tanaka; M Mera; Y Yanagihara
Journal:  Jpn J Microbiol       Date:  1973-03

3.  Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis.

Authors:  A Adam; R Ciorbaru; J F Petit; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

4.  Adjuvant-polyarthritogenicity of cell walls of mycobacteria, nocardia and corynebacteria.

Authors:  I Azuma; F Kanetsuna; Y Kada; T Takashima; Y Yamamura
Journal:  Jpn J Microbiol       Date:  1972-07

5.  Adjuvanticity of mycobacterial cell walls.

Authors:  I Azuma; S Kishimoto; Y Yamamura; J F Petit
Journal:  Jpn J Microbiol       Date:  1971-03

6.  Effects of oil-treated mycobacterial cell walls on the organs of mice.

Authors:  W R Barclay; R Anacker; W Brehmer; E Ribi
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

7.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

8.  Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey.

Authors:  I Azuma; D W Thomas; A Adam; J M Ghuysen; R Bonaly; J F Petit; E Lederer
Journal:  Biochim Biophys Acta       Date:  1970-06

Review 9.  The mycobacterial cell wall.

Authors:  E Lederer
Journal:  Pure Appl Chem       Date:  1971       Impact factor: 2.453

10.  Factors influencing protection against experimental tuberculosis in mice by heat-stable cell wall vaccines.

Authors:  E Ribi; R L Anacker; W Brehmer; G Goode; C L Larson; R H List; K C Milner; W C Wicht
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

View more
  3 in total

1.  Hydrosoluble immunostimulants of bacterial and synthetic origins.

Authors:  P Jollès
Journal:  Experientia       Date:  1976-06-15

2.  Adjuvant disease induced by mycobacteria, determinants of arthritogenicity.

Authors:  F Audibert; L Chedid
Journal:  Agents Actions       Date:  1976-02

3.  Adjuvant and mitogenic properties of a supernatant fraction of sonically treated Myobacterium bovis (BCG).

Authors:  L A Baker; T Sharpton; P Minden; P A Campbell
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.